JPMORGAN CHASE & CO - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$20,629
-26.3%
5,911
-55.5%
0.00%
Q3 2022$28,000
+154.5%
13,278
+221.9%
0.00%
Q2 2022$11,000
-89.6%
4,125
-83.0%
0.00%
Q1 2022$106,000
+10500.0%
24,273
+15764.7%
0.00%
Q2 2021$1,000
-97.9%
153
-97.6%
0.00%
Q1 2021$47,000
-81.5%
6,404
-79.5%
0.00%
Q4 2020$254,000
+225.6%
31,268
+213.1%
0.00%
Q3 2020$78,000
+27.9%
9,985
-10.6%
0.00%
Q2 2020$61,00011,1710.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,040,000$32,845,0004.29%
AWM Investment Company, Inc. 971,681$7,900,0001.00%
Diametric Capital, LP 51,633$420,0000.33%
Mesirow Financial Investment Management, Inc. 1,046$8,504,0000.03%
Hood River Capital Management LLC 76,397$621,0000.02%
Westside Investment Management, Inc. 83,900$4,743,0000.01%
MML INVESTORS SERVICES, LLC 129,250$1,051,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 31,961$260,0000.01%
TWO SIGMA INVESTMENTS, LP 126,490$1,028,0000.00%
SEI INVESTMENTS CO 76,397$621,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders